Literature DB >> 6265159

Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.

A Thabaut, J L Durosoir, P Saliou.   

Abstract

The in vitro activity of 8 cephalosporins - cephalothin, cefamandole, cefoxitin, cefuroxime, cefotaxime, cefoperazone, moxalactam and ceftriaxone (Rocephin) was studied on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis, isolated from pathological material. Determination of the MICs of these antibiotics by an agar dilution method shows that on N. gonorrhoeae ceftriaxone (geometric mean of the MICs: 0.0008 microgram/ml) is the most active, followed by cefotaxime (0.001 microgram/ml); cefoperazone (0.008 microgram/ml) and moxalactam (0.01 microgram/ml) are one-tenth as active; then come cefuroxime (0.05 microgram/ml), cefamandole (0.10 microgram/ml) and finally cephalothin (0.26 microgram/ml) and cefoxitin (0.26 microgram/ml). The least susceptibility to penicillin and, to a greater degree, the production of beta-lactamase (8 strains) affect the level of susceptibility to these cephalosporins, but the MICs always remain relatively low.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265159     DOI: 10.1159/000238024

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  8 in total

1.  Deciphering the Function of New Gonococcal Vaccine Antigens Using Phenotypic Microarrays.

Authors:  Benjamin I Baarda; Sarah Emerson; Philip J Proteau; Aleksandra E Sikora
Journal:  J Bacteriol       Date:  2017-08-08       Impact factor: 3.490

2.  Influence of inoculum size on comparative susceptibilities of penicillinase-positive and -negative Neisseria gonorrhoeae to 31 antimicrobial agents.

Authors:  W H Hall; B J Opfer
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

3.  Ceftriaxone versus povidone iodine in preventing wound infections following biliary surgery.

Authors:  R S Kiff; J Lomax; L Fowler; R D Kingston; E M Hoare; P A Sykes
Journal:  Ann R Coll Surg Engl       Date:  1988-09       Impact factor: 1.891

Review 4.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

5.  Ceftriaxone in the treatment of ordinary and penicillinase-producing strains of Neisseria gonorrhoeae.

Authors:  V S Rajan; E H Sng; T Thirumoorthy; C L Goh
Journal:  Br J Vener Dis       Date:  1982-10

6.  Comparison of the activities of ceftriaxone and penicillin G against experimentally induced syphilis in rabbits.

Authors:  R C Johnson; R F Bey; S J Wolgamot
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

7.  Randomised comparative study of ceftriaxone and spectinomycin in gonorrhoea.

Authors:  K Panikabutra; C Ariyarit; A Chitwarakorn; C Saensanoh; C Wongba
Journal:  Genitourin Med       Date:  1985-04

Review 8.  Clinical pharmacokinetics of ceftriaxone.

Authors:  J H Yuk; C H Nightingale; R Quintiliani
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.